OnCore Login

Return to Trial Database

HCRN-COE-05

A Retrospective Analysis of Proteomic, Genomic, and Pharmacogenetics in Patients Receiving Systemic Chemotherapy for Locally Advanced or Metastatic Breast Cancer

Status

Study Completed

Cancer Type(s)

Breast

Study Contact

Publications

Gene expression combined with gene set enrichment analysis to identify markers of vinorelbine efficacy in breast cancer patients
  • R Audet, C Shen, S Willis, R Duchnowska, K Adamowicz, J Zok, W Rogowski, MM Litwiniuk, S Debska, M Jaworska, M Foszczynska-Kloda, M Kulma-Kreft, K Zabkowska, J Jassem, S Edgerton, AD Thor, K Miller, GW Sledge, B Leyland-Jones
Thymidilate synthase gene copy number as predictive marker of capecitabine efficacy in breast cancer patients
  • R Audet, R Duchnowska, K Adamowicz, J Zok, W Rogowski, M Litwiniuk, S Debska, M Jaworska, M Foszczynska-Kloda, M Kulma-Kreft, K Zabkowska, C Shen, S Edgerton, K Vang Nielsen, A Thor, J Chang, K Miller, J Jassem, G Sledge, B Leyland-Jones
A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples
  • CP Riley, X Zhang, H Nakshatri, B Schneider, FE Regnier, J Adamec, C Buck

Trial Locations

All sites in which the trial HCRN-COE-05 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278